Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garret A FitzGerald

Showing results (11-20 of 301) with videos related to

Pageof 31
Sort By:
The American Journal of Cardiology|March 23, 2002
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approachGarret A FitzGerald
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2008
Translational therapeutics at the platelet vascular interface. IntroductionGarret A FitzGerald
Science Translational Medicine|October 5, 2012
"What great creation". Interview by Alisa M. ClyneGarret A FitzGerald
Science (New York, N.Y.)|March 22, 2020
Misguided drug advice for COVID-19Garret A FitzGerald
Journal of Lipid Research|June 13, 2022
COVID-19: lipid disruption is pushing the envelopeGarret A FitzGerald
Lancet (London, England)|February 25, 2003
Parsing an enigma: the pharmacodynamics of aspirin resistanceGarret A FitzGerald
Trends in Pharmacological Sciences|June 19, 2007
COX-2 in play at the AHA and the FDAGarret A FitzGerald
The Mount Sinai Journal of Medicine, New York|August 6, 2010
Perestroika in pharma: evolution or revolution in drug development?Garret A FitzGerald
Circulation Research|March 29, 2014
Testing cardiovascular drug safety and efficacy in randomized trialsGarret A FitzGerald
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 21, 2025
Segregate Assessment of Data Validity from the More Complex Issue of FraudGarret A FitzGerald
Pageof 31

Showing results (11-20 of 301) with videos related to

Sort By:
Pageof 31
The American Journal of Cardiology|March 23, 2002
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approachGarret A FitzGerald
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2008
Translational therapeutics at the platelet vascular interface. IntroductionGarret A FitzGerald
Science Translational Medicine|October 5, 2012
"What great creation". Interview by Alisa M. ClyneGarret A FitzGerald
Science (New York, N.Y.)|March 22, 2020
Misguided drug advice for COVID-19Garret A FitzGerald
Journal of Lipid Research|June 13, 2022
COVID-19: lipid disruption is pushing the envelopeGarret A FitzGerald
Lancet (London, England)|February 25, 2003
Parsing an enigma: the pharmacodynamics of aspirin resistanceGarret A FitzGerald
Trends in Pharmacological Sciences|June 19, 2007
COX-2 in play at the AHA and the FDAGarret A FitzGerald
The Mount Sinai Journal of Medicine, New York|August 6, 2010
Perestroika in pharma: evolution or revolution in drug development?Garret A FitzGerald
Circulation Research|March 29, 2014
Testing cardiovascular drug safety and efficacy in randomized trialsGarret A FitzGerald
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 21, 2025
Segregate Assessment of Data Validity from the More Complex Issue of FraudGarret A FitzGerald
Pageof 31